Skip to main content
. 2017 Apr 21;21(9):2163–2171. doi: 10.1111/jcmm.13140

Figure 5.

Figure 5

Effects of melatonin on BDNF and GDNF contents of NSCs treated with IL‐18. (A) BDNF and (B) GDNF contents, (CD) The mRNA level of BDNF (C) and mRNA level GDNF (D) in NSCs treated with or without IL‐18 and/or melatonin (10 ng/ml) in the presence or absence of luzindole (5 μM). (EF) The protein levels of BDNF and GDNF. ***P < 0.001.